Green Thumb Industries (GTBIF) Change in Receivables (2019 - 2026)
Green Thumb Industries (GTBIF) posted Change in Receivables of $628000.0 for Q1 2026, up 636.75% on a QoQ basis from -$117000.0 in Q4 2025, and up 111.69% year-over-year from $296659.9 in Q1 2025.
Green Thumb Industries (GTBIF) Change in Receivables (2019 - 2026) Analysis & Trends
Green Thumb Industries' Change in Receivables history runs 8 years deep, the most recent figure standing at $628000.0 for Q1 2026.
- Quarterly Change in Receivables rose 111.69% year-over-year to $628000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 203.92% YoY) and the FY2025 annual result came in at -$1.1 million, down 111.09% from the prior year.
- Change in Receivables was $628000.0 for Q1 2026 at Green Thumb Industries, up from -$117000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $9.2 million in Q1 2024 and bottomed at -$5.4 million in Q1 2025.
- A 5-year average of $1.8 million and a median of $150000.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 76616.67% — and 2025, when it plunged 158.35%.
- Green Thumb Industries' Change in Receivables stood at $150000.0 in 2022, then surged by 2784.67% to $4.3 million in 2023, then dropped by 10.58% to $3.9 million in 2024, then slumped by 103.02% to -$117000.0 in 2025, then surged by 636.75% to $628000.0 in 2026.
- Business Quant data shows GTBIF's Change in Receivables at $628000.0 in Q1 2026, -$117000.0 in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 628,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 628,000.00 |
| Mar 31, 2026 | 628,000.00 |
| Dec 31, 2025 | -117,000.00 |
| Dec 31, 2025 | -117,000.00 |
| Sep 30, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | -545,000.00 |
| Jun 30, 2025 | -545,000.00 |
| Mar 31, 2025 | -5.37 Mn |
| Mar 31, 2025 | -5.37 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Sep 30, 2024 | -372,000.00 |
| Sep 30, 2024 | -372,000.00 |
| Jun 30, 2024 | -2.85 Mn |
| Jun 30, 2024 | -2.85 Mn |
| Mar 31, 2024 | 9.21 Mn |
| Mar 31, 2024 | 9.21 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Dec 31, 2023 | 4.33 Mn |